First Bank & Trust bought a new stake in Gevo, Inc. (NASDAQ:GEVO – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 3,064,948 shares of the energy company’s stock, valued at approximately $6,007,000. Gevo accounts for approximately 1.0% of First Bank & Trust’s investment portfolio, making the stock its 16th largest holding. First Bank & Trust owned approximately 1.27% of Gevo at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Geode Capital Management LLC grew its position in Gevo by 104.5% in the 2nd quarter. Geode Capital Management LLC now owns 5,623,004 shares of the energy company’s stock valued at $7,424,000 after buying an additional 2,873,940 shares during the last quarter. Rhumbline Advisers acquired a new stake in shares of Gevo in the 2nd quarter worth $383,000. Quantbot Technologies LP acquired a new stake in shares of Gevo in the 2nd quarter worth $245,000. OMERS ADMINISTRATION Corp boosted its holdings in shares of Gevo by 114.5% in the first quarter. OMERS ADMINISTRATION Corp now owns 289,300 shares of the energy company’s stock valued at $336,000 after acquiring an additional 154,400 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of Gevo during the second quarter worth about $167,000. Hedge funds and other institutional investors own 35.17% of the company’s stock.
Gevo Price Performance
GEVO stock opened at $2.16 on Friday. The firm has a 50 day moving average of $2.22 and a 200-day moving average of $1.82. The company has a market cap of $523.39 million, a price-to-earnings ratio of -10.80 and a beta of 1.44. The company has a current ratio of 1.91, a quick ratio of 1.60 and a debt-to-equity ratio of 0.29. Gevo, Inc. has a 12-month low of $0.92 and a 12-month high of $2.98.
Insider Buying and Selling at Gevo
In other Gevo news, COO Christopher Michael Ryan sold 100,000 shares of Gevo stock in a transaction dated Wednesday, October 15th. The shares were sold at an average price of $2.82, for a total transaction of $282,000.00. Following the completion of the transaction, the chief operating officer owned 1,531,938 shares in the company, valued at approximately $4,320,065.16. The trade was a 6.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Andrew Shafer sold 29,797 shares of the company’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $2.28, for a total transaction of $67,937.16. Following the completion of the sale, the insider directly owned 285,823 shares in the company, valued at $651,676.44. This trade represents a 9.44% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 396,238 shares of company stock worth $960,518. Insiders own 6.80% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research firms recently issued reports on GEVO. HC Wainwright reissued a “buy” rating on shares of Gevo in a report on Wednesday, October 15th. UBS Group boosted their target price on Gevo from $1.15 to $2.25 and gave the stock a “neutral” rating in a research report on Wednesday, September 17th. Wall Street Zen raised Gevo from a “sell” rating to a “hold” rating in a research note on Saturday, September 13th. Weiss Ratings restated a “sell (d-)” rating on shares of Gevo in a research note on Wednesday, October 8th. Finally, Northland Securities began coverage on Gevo in a report on Monday, December 1st. They set an “outperform” rating and a $3.00 price objective on the stock. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Gevo currently has a consensus rating of “Moderate Buy” and a consensus price target of $6.42.
View Our Latest Research Report on GEVO
About Gevo
Gevo, Inc (NASDAQ: GEVO) is a renewable chemicals and biofuels company that develops and produces low-carbon alternatives to petroleum-based products. The company’s core technology platform converts fermentable sugars into isobutanol, which can be further processed into sustainable aviation fuel (SAF), renewable gasoline, diesel, and jet fuel. Gevo’s integrated biorefinery model combines fermentation, recovery, and downstream processing to deliver scalable, drop-in replacements for conventional fossil-derived hydrocarbons.
Gevo’s primary products include isobutanol, a four-carbon alcohol used as a building block for various fuels and chemicals, and hydrocarbon fuels that meet ASTM specifications for aviation and road transport.
Recommended Stories
- Five stocks we like better than Gevo
- What is a Secondary Public Offering? What Investors Need to Know
- These 3 Banks Are Rallying Into Year-End, But Will It Continue?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&P 500
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- This ETF Caught a Major Tailwind After the Fed’s Rate Cut
Want to see what other hedge funds are holding GEVO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Gevo, Inc. (NASDAQ:GEVO – Free Report).
Receive News & Ratings for Gevo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo and related companies with MarketBeat.com's FREE daily email newsletter.
